Education
About Us
Working with TipRanks
Follow Us
Treatment.Com International, Inc. (TSE:TRUE)
:TRUE
RESEARCH TOOLSreports
TRUE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.33 - C$0.93
Previous CloseN/A
Volume12.50K
Average Volume (3M)158.18K
Market Cap
C$32.09M
Enterprise ValueC$26.53M
Total Cash (Recent Filing)C$2.32M
Total Debt (Recent Filing)C$152.00K
Price to Earnings (P/E)―
Beta-0.27
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding75,502,396
10 Day Avg. Volume173,235
30 Day Avg. Volume158,181
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)8.72
Price to Sales (P/S)0.00
P/FCF Ratio-5.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Treatment.com International News
PremiumCompany Announcements
Treatment.com AI Enhances Marketing and Investor Relations Efforts
PremiumCompany Announcements
Rocket Doctor’s Virtual ED Program Eases Hospital Strain in Canada
PremiumCompany Announcements
Treatment.com AI Expands Virtual Care Reach with Rocket Doctor AcquisitionPremiumCompany Announcements
Treatment.com AI Inc. Grants Stock Options and Launches Media Campaign
PremiumCompany Announcements
Treatment.com AI Launches AI-Powered Medical Education Suite
Options Prices
Currently, No data available
---
Ownership Overview
0.17% Insiders
―
Mutual Funds
― Other Institutional Investors
99.83% Public Companies and
Individual Investors
TRUE FAQ
What was Treatment.Com International, Inc.’s price range in the past 12 months?
Treatment.Com International, Inc. lowest stock price was C$0.33 and its highest was C$0.93 in the past 12 months.
What is Treatment.Com International, Inc.’s market cap?
Treatment.Com International, Inc.’s market cap is C$32.09M.
When is Treatment.Com International, Inc.’s upcoming earnings report date?
Treatment.Com International, Inc.’s upcoming earnings report date is Aug 27, 2025 which is in 35 days.
How were Treatment.Com International, Inc.’s earnings last quarter?
Treatment.Com International, Inc. released its earnings results on May 30, 2025. The company reported -C$0.041 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.041.
Is Treatment.Com International, Inc. overvalued?
According to Wall Street analysts Treatment.Com International, Inc.’s price is currently Overvalued.
Does Treatment.Com International, Inc. pay dividends?
Treatment.Com International, Inc. does not currently pay dividends.
What is Treatment.Com International, Inc.’s EPS estimate?
Treatment.Com International, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Treatment.Com International, Inc. have?
Treatment.Com International, Inc. has 75,502,396 shares outstanding.
What happened to Treatment.Com International, Inc.’s price movement after its last earnings report?
Treatment.Com International, Inc. reported an EPS of -C$0.041 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.846%.
Which hedge fund is a major shareholder of Treatment.Com International, Inc.?
Currently, no hedge funds are holding shares in TSE:TRUE
Company Description
Treatment.Com International, Inc.
Treatment.com International (TRUE) is a healthcare technology company that focuses on developing digital platforms and solutions to enhance healthcare delivery and patient outcomes. The company operates in the intersection of technology and healthcare sectors, providing innovative tools that leverage artificial intelligence and machine learning to improve diagnosis, treatment planning, and patient engagement.